Skip over navigation
The Hospital
Research
Support Us
Ottawa Hospital Research Institute
Home
Français
Directions & Maps
Contact Us
About Us
Vision and Strategic Directions
Board Chair and CEO Message
Leadership Team
Annual Reports
Facilities
Research Data Management
Equity, Diversity and Inclusion
Wellness
Our Research
Priorities, Programs and Diseases
Researcher Profiles
National Research Networks
Scientific Publications
Research Awards
Technology Transfer
Industry Sponsored Research
Responsible Innovation
For Students & Fellows
News & Events
Newsroom
Seminars & Events
Career Opportunities
For Patients
News & Events
Home
>
News & Events
>
Newsroom
Bookmark or Share
Display Options
Display Options
+
Increase
/
-
Decrease
font size
High contrast version
Printer-friendly version
Newsroom
Seminars & Events
Newsroom
Clinical trial launched to research the benefits of taking folic acid during pregnancy
August 18, 2014
Drs.
Mark Walker
and
Shi-Wu Wen
have launched a clinical trial to evaluate the effectiveness of folic acid in preventing preeclampsia in pregnant women. Preeclampsia affects about five per cent of pregnant women worldwide, and is characterized by high blood pressure and leakage of protein into the urine. Preeclampsia is responsible for one-third of all pregnancy-related deaths worldwide. Currently, the only way to cure preeclampsia is to deliver a baby – which often happens weeks before the due date resulting in preterm births. Now, Drs. Walker and Wen will test whether high doses of folic acid administered throughout a pregnancy in women at high risk for preeclampsia can prevent this disease from developing in an international, multi-centre, randomised, double-blind, placebo-controlled trial involving 3,656 women, funded by the
Canadian Institutes of Health Research
(CIHR). The doctors believe that their trial will provide solid scientific rationale for the use of high doses of folic acid during pregnancy. They are also eager to explore whether taking folic acid during pregnancy has long-term impacts on the health of women and their babies.
Read about the clinical trial
.
>> See article in
International Innovation
.
About the Ottawa Hospital Research Institute
The Ottawa Hospital Research Institute (OHRI) is the research arm of The Ottawa Hospital and is an affiliated institute of the University of Ottawa, closely associated with the university’s Faculties of Medicine and Health Sciences. OHRI includes more than 1,700 scientists, clinical investigators, graduate students, postdoctoral fellows and staff conducting research to improve the understanding, prevention, diagnosis and treatment of human disease.
Media contact
Paddy Moore
Communications and Public Relations
Ottawa Hospital Research Institute
613-737-8899 x73687
613-323-5680 (cell)